Ketobemidone

This classification denotes an opioid receptor agonist with the molecular formula C15H21NO2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier PQS1L514CF, chemically known as 1-propanone, 1-(4-(m-hydroxyphenyl)-1-methyl-4-piperidyl)- (8ci) but generally known as ketobemidone, which bears US NIH Compound Identifier 10101. European Medicines Agency schedules Ketobemidone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08370MIG. The term KETOBEMIDONE is an International Non-Proprietary Name. World Health Organization schedules ketobemidone in its Anatomical Therapeutic Chemical (ATC) Classification. KETOBEMIDONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ketobemidone under HS 29333300 and SITC 51574. As of Q4 2014, KETOBEMIDONE remains the US FDA Preferred Term for this commodity. Ketobemidone bears US NLM identifiers UMLS ID C0064311 and NCI Concept Code C80583. SMILES: O=C(C1(CCN(CC1)C)C1CC(O)CCC1)CC.